KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection

Cellular Immunology

Volumn 283, Issue 1-2, 2013, Pages 1-7

  Mgbemena, Victoria ^a   Segovia, Jesus ^a   Chang, Te Hung ^a   Bose, Santanu ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Apoptosis; Inducible nitric oxide synthase; Kruppel like factor 6; Nitric oxide; Respiratory syncytial virus; Transcription factor

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; KRUPPEL LIKE FACTOR 6;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

APOPTOSIS; BMDMS; BONE MARROW-DERIVED MACROPHAGES; CHIP; CHROMATIN IMMUNO-PRECIPITATION; INDUCIBLE NITRIC OXIDE SYNTHASE; INOS; KLF6; KNOCK-OUT; KO; KRUPPEL-LIKE FACTOR 6; L-NIL; N(6)-(1-IMINOETHYL)-L-LYSINE DIHYDROCHLORIDE; NITRIC OXIDE; NO; RESPIRATORY SYNCYTIAL VIRUS; RSV; TRANSCRIPTION FACTOR; WILD TYPE; WT;

ANIMALS; APOPTOSIS; CHROMATIN IMMUNOPRECIPITATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84880377986     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.06.002     Document Type: Article

References (54)

1. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 2001, 344:1917-1928.
2. Collins P.L., McIntosh K., Chanock R.M. Respiratory syncytial virus. Fields Virology 2007, 1601-1640. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
3. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 2005, 352:1749-1759.
4. Ruuskanen O., Lahti E., Jennings L.C., Murdoch D.R. Viral pneumonia. Lancet 2011, 377:1264-1275.
5. Pautz A., Art J., Hahn S., Nowag S., Voss C., Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 2010, 23:75-93.
6. Vareille M., Kieninger E., Edwards M.R., Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 2011, 24:210-229.
7. O'Reilly P., Hickman-Davis J.M., McArdle P., Young K.R., Matalon S. The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A. Mol. Cell. Biochem. 2002, 234-235:39-48.
8. Richardson A.R., Libby S.J., Fang F.C. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 2008, 319:1672-1676.
9. Zheng S., De B.P., Choudhary S., Comhair S.A., Goggans T., Slee R., Williams B.R., Pilewski J., Haque S.J., Erzurum S.C. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity 2003, 18:619-630.
10. Zheng S., Xu W., Bose S., Banerjee A.K., Haque S.J., Erzurum S.C. Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L374-L381.
11. Bove P.F., van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic. Biol. Med. 2006, 41:515-527.
12. Akaike T., Maeda H. Nitric oxide and virus infection. Immunology 2000, 101:300-308.
13. + channels by up-regulating inducible nitric-oxide synthase. J. Biol. Chem. 2009, 11:7294-7306.
14. Stark J.M., Khan A.M., Chiappetta C.L., Xue H., Alcorn J.L., Colasurdo G.N. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection. J. Infect. Dis. 2005, 191:387-395.
15. Kao Y.J., Piedra P.A., Larsen G.L., Colasurdo G.N. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 2001, 163:532-539.
16. Maa S.H., Wang C.H., Liu C.Y., Lin H.C., Huang K.H., Kuo H.P. Endogenous nitric oxide downregulates the Bcl-2 expression of eosinophils through mitogen-activated protein kinase in bronchial asthma. J. Allergy Clin. Immunol. 2003, 112:761-767.
17. McConnell B.B., Yang V.W. Mammalian Krüppel-like factors in health and diseases. Physiol. Rev. 2010, 90:1337-1381.
18. Mgbemena V., Segovia J., Chang T., Tsai S.-Y., Cole G.T., Hung C.-Y., Bose S. Transactivation of inducible nitric oxide synthase gene by krüppel-like factor 6 regulates apoptosis during influenza A virus infections. J. Immunol. 2012, 189:606-615.
19. Sabbah A., Chang T., Harnack R., Frohlich V., Dube P.H., Tominaga K., Xiang Y., Bose S. Activation of innate immune antiviral response by Nod2. Nat. Immunol. 2009, 10:1073-1080.
20. Kota S., Sabbah A., Chang T.H., Harnack R., Xiang Y., Meng Y., Bose S. Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kB mediated innate anti-viral response against human respiratory syncytial virus. J. Biol. Chem. 2008, 283:22417-22429.
21. Bose S., Kar N., Maitra R., Didonato J., Banerjee A.K. Temporal activation of NF-κB regulates an interferon independent innate anti-viral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. USA 2003, 100:10890-10895.
22. Echchgadda I., Kota S., DeLa Cruz I., Sabbah A., Chatterjee B., Bose S. Anti-cancer oncolytic activity of respiratory syncytial virus. Cancer Gene Ther. 2009, 16:923-935.
23. Ueba O. Respiratory syncytial virus - concentration and purification of the infectious virus. Acta Med. Okayama 1978, 32:265-272.
24. Yao H., Hwang J., Moscat J., Diaz-Meco M.T., Leitges M., Kishore N., Li X., Rahman I. Protein kinase C mediates cigarette smoke/aldehyde- and lipopolysaccharide-induced lung inflammation and histone modifications. J. Biol. Chem. 2010, 285:5405-5416.
25. Kolodziejski P.J., Koo J.S., Eissa N.T. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc. Natl. Acad. Sci. USA 2004, 101:18141-18146.
26. Welliver T.P., Garofalo R.P., Hosakote Y., Hintz K.H., Avendano L., Sanchez K., Velozo L., Jafri H., Chavez-Bueno S., Ogra P.L., McKinney L., Reed J.L., Welliver R.C. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 2007, 195:1126-1136.
27. Vandivier R.W., Henson P.M., Douglas I.S. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006, 129:1673-1682.
28. Zhang C., Yang Y., Zhou X., Liu X., Song H., He Y., Huang P. Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. Virol. J. 2010, 7:51.
29. Herold S., Steinmueller M., von Wulffen W., Cakarova L., Pinto R., Pleschka S., Mack M., Kuziel W.A., Corazza N., Brunner T., Seeger W., Lohmeyer J. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 2008, 205:3065-3077.
30. Uetani K., Der S.D., Zamanian-Daryoush M., de La Motte C., Lieberman B.Y., Williams B.R., Erzurum S.C. Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J. Immunol. 2000, 165:988-996.
31. Karupiah G., Chen J.H., Mahalingam S., Nathan C.F., MacMicking J.D. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 1998, 188:1541-1546.
32. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., Dietzschold B., Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 1996, 93:2448-2453.
33. Burggraaf S., Bingham J., Payne J., Kimpton W.G., Lowenthal J.W., Bean A.G. Increased inducible nitric oxide synthase expression in organs is associated with a higher severity of H5N1 influenza virus infection. PLoS One 2011, 6:e14561.
34. Gadish T., Soferman R., Merimovitch T., Fireman E., Sivan Y. Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis. Arch. Pediatr. Adolesc. Med. 2010, 164:727-731.
35. Kato M., Hayashi Y., Kimura H. Oxygen radicals in inflammation and allergy related to viral infections. Curr. Drug Targets Inflamm. Allergy 2005, 4:497-501.
36. Bem R.A., Bos A.P., Wösten-van Asperen R.M., Bruijn M., Lutter R., Sprick M.R., van Woensel J.B. Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am. J. Respir. Cell Mol. Biol. 2010, 42:697-705.
37. Aherne W., Bird T., Court S.D., Gardner P.S., McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 1970, 23:7-18.
38. Johnson J.E., Gonzales R.A., Olson S.J., Wright P.F., Graham B.S. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 2007, 20:108-119.
39. Eckardt-Michel J., Lorek M., Baxmann D., Grunwald T., Keil G.M., Zimmer G. The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J. Virol. 2008, 82:3236-3249.
40. Kotelkin A., Prikhod'ko E.A., Cohen J.I., Collins P.L., Bukreyev A. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J. Virol. 2003, 77:9156-9172.
41. O'donnell D.R., Milligan L., Stark J.M. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 1999, 257:198-207.
42. Bitko V., Shulyayeva O., Mazumder B., Musiyenko A., Ramaswamy M., Look D.C., Barik S. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J. Virol. 2007, 81:1786-1795.
43. Thomas K.W., Monick M.M., Staber J.M., Yarovinsky T., Carter A.B., Hunninghake G.W. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 2002, 277:492-501.
44. Groskreutz D.J., Monick M.M., Yarovinsky T.O., Powers L.S., Quelle D.E., Varga S.M., Look D.C., Hunninghake G.W. Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J. Immunol. 2007, 179:2741-2747.
45. Bitko V., Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J. Cell. Biochem. 2001, 80:441-454.
46. Jiang J., George S.C. TGF-β2 reduces nitric oxide synthase mRNA through a ROCK-dependent pathway in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L361-L367.
47. Takaki H., Minoda Y., Koga K., Takaesu G., Yoshimura A., Kobayashi T. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation. Genes Cells 2006, 11:871-882.
48. Mitani T., Terashima M., Yoshimura H., Nariai Y., Tanigawa Y. TGF-beta1 enhances degradation of IFN-gamma-induced iNOS protein via proteasomes in RAW 264.7 cells. Nitric Oxide 2005, 13:78-87.
49. Mgbemena V., Segovia J., Chang T., Bose S. Krüppel-like factor 6 regulates transforming growth factor-beta gene expression during human respiratory syncytial virus infection. Virol. J. 2011, 8:409.
50. DiFeo A., Narla G., Camacho-Vanegas O., Nishio H., Rose S.L., Buller R.E., Friedman S.L., Walsh M.J., Martignetti J.A. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene 2006, 25:6026-6031.
51. Kim Y., Ratziu V., Choi S.G., Lalazar A., Theiss G., Dang Q., Kim S.J., Friedman S.L. Transcriptional activation of transforming growth factor beta1 and its receptors by the kruppel-like factor Zf9/core promoter binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J. Biol. Chem. 1998, 273:33750-33758.
52. Ratziu V., Lalazar A., Wong L., Dang Q., Collins C., Shaulian E., Jensen S., Friedman S.L. Zf9, a kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc. Natl. Acad. Sci. USA 1998, 95:9500-9505.
53. Kojima S., Hayashi S., Shimokado K., Suzuki Y., Shimada J., Crippa M.P., Friedman S.L. Transcriptional activation of urokinase by the kruppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood 2000, 95:1309-1316.
54. Warke V.G., Nambiar M.P., Krishnan S., Tenbrock K., Geller D.A., Koritschoner N.P., Atkins J.L., Farber D.L., Tsokos G.C. Transcriptional activation of the human inducible nitric-oxide synthase promoter by kruppel-like factor 6. J. Biol. Chem. 2003, 278:14812-14819.